LncMiM
LncMiM identifies lncRNA–miRNA–mRNA competing triplets and associated prognostic biomarkers in high-grade serous ovarian cancer using tumor expression data.
Key Features:
- Novel Methodology: Detects lncRNA–miRNA–mRNA competing triplets from tumor samples in the TCGA database using non-linear correlation analysis to address weak correlations between miRNA–target pairs and differences in expression levels.
- Comprehensive Analysis: Integrates lncRNA, miRNA, and mRNA expression relationships to consider the impact of lncRNAs and mRNAs on miRNA–target interactions.
- Extensive Network Mapping: Identified 847 lncRNA-associated competing triplets forming a regulatory network centered on miRNA–lncRNA pairs, with highly connected lncRNAs including ZFAS1, SNHG29, GAS5, AC112491.1, and AC099850.4.
- Biological Insights: Performs biological process and KEGG pathway enrichment analyses linking competing triplets to cell division, proliferation, cell cycle regulation, oocyte meiosis, oxidative phosphorylation, ribosome function, and the p53 signaling pathway.
- Prognostic Biomarker Identification: Performs survival analysis to nominate 107 potential prognostic biomarkers among competing triplets, including FGD5-AS1, HCP5, HMGN4, and TACC3.
Scientific Applications:
- Regulatory network mapping: Maps miRNA–lncRNA-centered regulatory networks in high-grade serous ovarian cancer and reports 847 competing triplets.
- Prognostic biomarker discovery: Identifies candidate prognostic biomarkers via survival analysis, nominating 107 candidates such as FGD5-AS1, HCP5, HMGN4, and TACC3.
- Pathway and mechanism inference: Associates competing triplets with biological processes and KEGG pathways (including oocyte meiosis, oxidative phosphorylation, ribosome, and the p53 signaling pathway) to inform mechanistic hypotheses.
Methodology:
Analysis uses tumor samples from the TCGA database, applies non-linear correlation analysis to detect lncRNA–miRNA–mRNA competing triplets, and employs biological process and KEGG pathway enrichment analysis and survival analysis.
Topics
Details
- License:
- MIT
- Tool Type:
- command-line tool, library
- Programming Languages:
- R
- Added:
- 3/19/2021
- Last Updated:
- 4/11/2021
Operations
Publications
Zhao J, Song X, Xu T, Yang Q, Liu J, Jiang B, Wu J. Identification of Potential Prognostic Competing Triplets in High-Grade Serous Ovarian Cancer. Frontiers in Genetics. 2021;11. doi:10.3389/fgene.2020.607722. PMID:33519912. PMCID:PMC7839966.
PMID: 33519912
PMCID: PMC7839966
Funding: - China Postdoctoral Science Foundation: 2019M661817
- National Natural Science Foundation of China: 61901225, 61973155, 62003165
- Fundamental Research Funds for the Central Universities: NP2018109